Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RAMM.CNthis companyRAMM Pharma Corp.	CA$0.02	-0.2×	0.31×	0.53×	-0.28×	-1077.1%	11.1%	-134.4%	-265.1%	-156.4%	-78.2%	-59.2%	0.01×	0.19×	-17.59×	0.74×	0.0%	1	-18.1	2	C+
PHRX.CNPharmadrug Inc.	CA$0.01	-4.17×	-0.92×	0×	-43.31×	-437.1%	0.0%	0.0%	0.0%	21.7%	-144.3%	-5.4%	-0.86×	-20.78×	-0.73×	0.02×	0.0%	2	-78.75	2	C
Peer median	—	-4.17×	-0.92×	0×	-43.31×	-437.1%	0.0%	0.0%	0.0%	21.7%	-144.3%	-5.4%	-0.86×	-20.78×	-0.73×	0.02×	0.0%	2	-78.75	2	—